HSPB8 Protein

HSPB8 Protein

Introduction

<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">HSPB8 Protein</th>
</tr>
<tr>
<td class="label">Symbol</td>
<td><strong>HSPB8</strong></td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>HSPB8</td>
</tr>
<tr>
<td class="label">Type</td>
<td>Protein</td>
</tr>
<tr>
<td class="label">UniProt</td>
<td><a href="https://www.uniprot.org/uniprot/?query=HSPB8" target="_blank">Search UniProt</a></td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/als" style="color:#ef9a9a">ALS</a>, <a href="/wiki/als" style="color:#ef9a9a">Als</a>, <a href="/wiki/amyotrophic-lateral-sclerosis" style="color:#ef9a9a">Amyotrophic Lateral Sclerosis</a>, <a href="/wiki/ataxia" style="color:#ef9a9a">Ataxia</a>, <a href="/wiki/huntington" style="color:#ef9a9a">Huntington</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">157 edges</a></td>
</tr>
</table>

HSPB8 Protein

Introduction

<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">HSPB8 Protein</th>
</tr>
<tr>
<td class="label">Symbol</td>
<td><strong>HSPB8</strong></td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>HSPB8</td>
</tr>
<tr>
<td class="label">Type</td>
<td>Protein</td>
</tr>
<tr>
<td class="label">UniProt</td>
<td><a href="https://www.uniprot.org/uniprot/?query=HSPB8" target="_blank">Search UniProt</a></td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/als" style="color:#ef9a9a">ALS</a>, <a href="/wiki/als" style="color:#ef9a9a">Als</a>, <a href="/wiki/amyotrophic-lateral-sclerosis" style="color:#ef9a9a">Amyotrophic Lateral Sclerosis</a>, <a href="/wiki/ataxia" style="color:#ef9a9a">Ataxia</a>, <a href="/wiki/huntington" style="color:#ef9a9a">Huntington</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">157 edges</a></td>
</tr>
</table>

HSPB8 (Heat Shock Protein Family B Member 8), also known as Hsp22 or CMT2L, is a member of the small heat shock protein (sHSP) family. Unlike larger [heat shock proteins](/entities/heat-shock-proteins), HSPB8 has unique molecular properties that make it particularly important in neuromuscular health and neurodegenerative diseases. It functions as a molecular chaperone that works in concert with Hsp70 and [autophagy](/entities/autophagy) adaptors to clear aggregation-prone proteins, a process critical for neuronal survival. [@fontaine2006]

[@crippa2010]

Overview

The HSPB8 gene encodes a 175-amino acid protein with a molecular weight of approximately 22 kDa. It is expressed predominantly in peripheral nerves, spinal cord, and brain regions including the [hippocampus](/brain-regions/hippocampus) and cerebral [cortex](/brain-regions/cortex). HSPB8 is characterized by its highly conserved α-crystallin domain, which mediates substrate binding and oligomerization. Mutations in HSPB8 cause Charcot-Marie-Tooth disease type 2 (CMT2L) and are implicated in amyotrophic lateral sclerosis (ALS), highlighting its essential role in motor neuron and peripheral nerve function. [@wilhelmus2006]

Structure

HSPB8 possesses several structural features: [@irobi2004]

• N-terminal Region: Variable sequence that contains substrate-binding motifs
• α-Crystallin Domain: The central ~90 amino acids form the conserved α-crystallin domain, characteristic of all small HSPs
• C-terminal Extension: Contains the IXI/V motif involved in oligomerization and interaction with co-chaperones

Normal Function

Molecular Chaperone Activity

HSPB8 functions as an ATP-independent chaperone with several key properties: [@carra2008]

The HSPB8-Hsp70-p62 Complex

HSPB8 works in a multiprotein chaperone complex:

• HSPB8: Recognizes and binds misfolded proteins
• Hsp70 (HSPA1A): Provides ATP-dependent refolding or targeting
• Hsp40 (DNAJB proteins): Co-chaperone that stimulates Hsp70 ATPase
• p62/SQSTM1: Autophagy adaptor that links ubiquitinated cargo to the autophagic machinery
• Hsp110: nucleotide exchange factor for Hsp70

Tissue-Specific Functions

• Peripheral nervous system: Maintains axonal integrity through transport protein clearance
• Motor [neurons](/entities/neurons): Supports protein homeostasis under metabolic stress
• Cardiac muscle: Protects against proteotoxic stress

Role in Neurodegenerative Diseases

Charcot-Marie-Tooth Disease Type 2L (CMT2L)

HSPB8 was first linked to CMT2L through identification of dominant mutations:

• Drupted axonal transport: Mutant HSPB8 leads to accumulation of protein aggregates in axons
• Loss of chaperone function: Some mutations impair the ability to clear misfolded proteins
• Distal axon degeneration: Longest axons are most affected, consistent with the length-dependent neuropathy phenotype

Amyotrophic Lateral Sclerosis (ALS)

HSPB8 plays a complex role in ALS:

• SOD1 mutations: HSPB8 helps clear mutant SOD1 aggregates
• [TDP-43](/mechanisms/tdp-43-proteinopathy) pathology: The chaperone complex can target TDP-43 aggregates
• [C9orf72](/entities/c9orf72) repeat expansions: HSPB8 activity may be beneficial in reducing dipeptide repeat protein toxicity
• **: OverProtective effectsexpression of HSPB8 in animal models improves motor neuron survival

Alzheimer's Disease

In Alzheimer's disease:

• [Tau](/proteins/tau) clearance: HSPB8 can facilitate autophagic clearance of hyperphosphorylated tau
• [Amyloid-beta](/proteins/amyloid-beta) response: May be upregulated as a protective response to Aβ toxicity
• Synaptic protection: Helps maintain synaptic protein homeostasis

Parkinson's Disease

• [Alpha-synuclein](/proteins/alpha-synuclein) clearance: HSPB8-p62-mediated autophagy can target α-synuclein aggregates
• Mitophagy: Supports removal of damaged mitochondria
• Dopaminergic neuron protection: May help maintain dopaminergic neuron health

Therapeutic Implications

Pharmacological Activation

Small molecule activators of HSPB8-mediated autophagy are being explored:

• Autophagy inducers: Rapamycin and analogous compounds enhance chaperone-assisted autophagy
• Hsp90 inhibitors: Ganetespib and other Hsp90 inhibitors shift proteostasis toward autophagy
• Natural compounds: Certain flavonoids and polyphenols can upregulate HSPB8 expression

Gene Therapy Approaches

• AAV-mediated delivery: Viral vectors encoding HSPB8 for peripheral nerve protection
• Combination therapy: HSPB8 with other protective proteins (e.g., Hsp70)

Biomarker Potential

HSPB8 expression levels in cerebrospinal fluid (CSF) and blood are being investigated as:

• Biomarkers for CMT2 progression
• Therapeutic response indicators
• Surrogate markers for autophagy activity

See Also

• [Hsp70 Protein](/proteins/hsp70-protein)
• [p62/SQSTM1](/proteins/sqstm1-protein)
• [Charcot-Marie-Tooth Disease](/diseases/charcot-marie-tooth-disease)
• [Amyotrophic Lateral Sclerosis](/diseases/amyotrophic-lateral-sclerosis)
• [Alzheimer's Disease](/diseases/alzheimers-disease)
• [Parkinson's Disease](/diseases/parkinsons-disease)
• [Autophagy](/mechanisms/autophagy)
• [Molecular Chaperones](/mechanisms/molecular-chaperones)
• [Protein Aggregation](/mechanisms/protein-aggregation)

Background

The study of Hspb8 Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

External Links

• [UniProt: Q9UJQ8 (HSPB8 Human)](https://www.uniprot.org/uniprot/Q9UJQ8)
• [GeneCards: HSPB8 Gene](https://www.genecards.org/cgi-bin/carddisp.pl?gene=HSPB8)
• [OMIM: 608655 (HSPB8; CMT2L)](https://www.omim.org/entry/608655)

References